Bliss GVS Pharma Reclassifies 27 Promoters to Public After Control Change

HEALTHCAREBIOTECH
Whalesbook Corporate News Logo
AuthorAarav Shah|Published at:
Bliss GVS Pharma Reclassifies 27 Promoters to Public After Control Change

Bliss GVS Pharma has officially reclassified 27 members of its promoter group to the public category following the completion of a share purchase agreement with Anupam Rasayan India. The outgoing promoters, led by Narsimha Shibroor Kamath, have divested their stake, reducing their collective holding from 34.82% to effectively nil. This move concludes the ownership transition process initiated earlier this year and aligns with SEBI takeover regulations, signaling a full transfer of control to the new management.

Bliss GVS Pharma Completes Promoter Reclassification

Outgoing promoters reduce collective stake from 34.82% to 0.01% as control shifts to new buyers.

Reader Takeaway: New management assumes full control while the former promoter group exits, ensuring compliance with SEBI regulatory standards.

What just happened

Bliss GVS Pharma has formally completed the process of reclassifying 27 individuals from the 'Promoter and Promoter Group' to the 'public' category. This follows the successful conclusion of a share purchase agreement (SPA) dated May 23, 2026, involving Anupam Rasayan India as the purchaser. The transition involved a significant divestment of shares, including the entire stake held by Narsimha Shibroor Kamath, who previously held 30.51% of the company's equity.

Why this matters

The reclassification marks the final step in a major change-in-control transaction. With the erstwhile promoters effectively vacating their positions and reducing their shareholding to negligible levels, the company is now fully under the guidance of the new promoters. For investors, this provides clarity on the ownership structure and confirms that the transition process is legally settled under SEBI guidelines.

The backstory

The process began with an open offer and a series of disclosures throughout 2026, including a Letter of Offer filed on July 18, 2026. The outgoing promoters have complied with all necessary SEBI regulations, specifically Regulation 31(A) of the Listing Regulations, which governs the conditions for reclassifying promoters to the public category.

Risks to watch

Investors should look for updates regarding potential shifts in the company’s business strategy or board-level appointments under the new leadership. While the change of control is complete, the operational integration and the long-term vision of the new promoters will be the primary drivers of future performance.

What to track next

Watch for upcoming board meeting minutes or management communications that outline the strategic roadmap for the company under its new ownership structure.

Disclaimer: This article is published for informational purposes only. This is not a buy sell recommendation.